Baricitinib vs Empagliflozin

Baricitinib vs Empagliflozin: Overview

This comparison examines the pharmacological differences between Baricitinib and Empagliflozin.

Mechanism of Action

Baricitinib: Selective JAK1 and JAK2 inhibitor blocking cytokine signaling involved in inflammation.

Empagliflozin: Selective SGLT2 inhibitor reducing renal glucose reabsorption.

Pharmacokinetics

Half-life: Baricitinib — 12 hours; Empagliflozin — 12.4 hours.

Chemical Properties

Molecular Formula: Baricitinib — C16H17N7O2S; Empagliflozin — C23H27ClO7.

Molecular Weight: Baricitinib — 371.4170 g/mol; Empagliflozin — 450.9100 g/mol.

Type: Baricitinib — Small molecule; Empagliflozin — Small molecule.